MR [Mindray Medical International] SC 13G/A: 1. Names of Reporting Persons. I.R.S. Identification Nos.

[1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Baillie Gifford & Co (Scottish partnership) _______________________________________________________________________ 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a).................................................................... (b).................................................................... _______________________________________________________________________ 3. SEC Use Only _______________________________________________________________________ 4. Citizenship or Place of Organization SCOTLAND UK _______________________________________________________________________ Number of 5. Sole Voting Power 7036961 Shares Bene ______________________________________________________]

DHRM [Dehaier Medical Systems] 20-F:

[] [I, Ping Chen, certify that: (1) I have reviewed this Form 20-F of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [Certification of Principal Financial Officer I, Jingli Li, certify that: (1) I have reviewed this Form 20-F of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Ping Chen] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Jingli Li Chief Financial Officer (Principal Financial Officer)] [Dehaier Medical Announces 2013 Full Year Financial Results Company to Conduct Conference Call at 9:00 p.m. on March 31, 2014 Dehaier Medical Systems Ltd. BEIJING, March. 31, 2014 — Mr. Ping Chen, Chief Executive Officer of Dehaier Medical, stated, “2013 was a year of strategic restructure of our business focuses and product offerings. We have maintained our growth in major]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces ADS Dividend Record Date for March 2014 Dividend SHENZHEN, China, March 7, 2014 — Mindray Medical International Limited (“Mindray”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today that, in accordance with NYSE rules, holders of record of Mindray ADSs at the close of business on March 14, 2014 are entitled to the] [3 EX-99.1 4]

MR [Mindray Medical International] 6-K: Mindray Announces ADS Dividend Record Date for March

[Mindray Announces ADS Dividend Record Date for March 2014 Dividend SHENZHEN, China, March 7, 2014 — Mindray Medical International Limited (“Mindray”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today that, in accordance with NYSE rules, holders of record of Mindray ADSs at the close of business on March 14, 2014 are entitled to the] [3 EX-99.1 4]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Increases its Existing Share Repurchase Program by $100 Million Shenzhen, China – March 3, 2014 – Mindray Medical International Limited (“Mindray” or “Company”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved to increase the size of its previously authorized share repurchase program from US$200 million to] [2 Mindray Medical International Limited]

MR [Mindray Medical International] 6-K: Mindray Increases its Existing Share Repurchase Program by

[Mindray Increases its Existing Share Repurchase Program by $100 Million Shenzhen, China – March 3, 2014 – Mindray Medical International Limited (“Mindray” or “Company”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved to increase the size of its previously authorized share repurchase program from US$200 million to] [2 Mindray Medical International Limited]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces 2013 Fourth Quarter and Full Year Results SHENZHEN, China, March. 3, 2014 — Mindray Medical International Limited (“Mindray”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2013. Highlights for Fourth Quarter and Full Year 2013 • Full] [EX-99.1 2]

MR [Mindray Medical International] 6-K: Mindray Announces 2013 Fourth Quarter and Full Year

[Mindray Announces 2013 Fourth Quarter and Full Year Results SHENZHEN, China, March. 3, 2014 — Mindray Medical International Limited (“Mindray”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2013. Highlights for Fourth Quarter and Full Year 2013 • Full] [EX-99.1 2]

DHRM [Dehaier Medical Systems] 6-K: (Original Filing)

[BEIJING, February 26, 2014 - Dehaier Medical Systems Ltd. Contact Us Dehaier Medical Systems Limited Surie Liu +86 10-5166-0080 lius@dehaier.com.cn Dehaier Medical Systems Limited Tina He +86 10-5166-0080 hexw@dehaier.com.cn] []

DHRM [Dehaier Medical Systems] 6-K: BEIJING, February 26, 2014 – Dehaier Medical Systems

[BEIJING, February 26, 2014 - Dehaier Medical Systems Ltd. Contact Us Dehaier Medical Systems Limited Surie Liu +86 10-5166-0080 lius@dehaier.com.cn Dehaier Medical Systems Limited Tina He +86 10-5166-0080 hexw@dehaier.com.cn] []

Skip to toolbar